In 2005, 1002 (39%) patients, with a mean age of 66.7 ± 8.6 years, responded to this follow-up screening, including 461 (aged 68.3 ± 8.7 years) males and 541 (65.3 ± 8.2 years) females.
China: A recent study published in the Annals of Hepatology has emphasized the influence of age on hepatocellular carcinoma ...
Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.
Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.
New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.
Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...
Emirates News Agency on MSN15d
Fujifilm showcases its latest solutions for early detection at Arab Health 2025Fujifilm Middle East and Africa part of the globally renowned Fujifilm Corporation is participating at Arab Health 2025 taking place between 27th a ...
Find Most Common Cancers And Prevention Latest News, Videos & Pictures on Most Common Cancers And Prevention and see latest updates, news, information from NDTV.COM. Explore more on Most Common ...
Vietnam Investment Review on MSN2d
Lion TCR s Liocyx M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV Related Hepatocellular CarcinomaOn 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an ...
In this community-based HCC screening on an aged population in an HCV-endemic township, we found that platelet count and AFP could be feasible markers for high-risk patient identification and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback